Artificial Intelligence-Powered Blockchains for Cardiovascular Medicine

被引:22
作者
Krittanawong, Chayakrit [1 ]
Aydar, Mehmet [2 ]
Virk, Hafeez Ul Hassan [3 ]
Kumar, Anirudh [4 ]
Kaplin, Scott [5 ]
Guimaraes, Lucca [6 ]
Wang, Zhen [7 ,8 ]
Halperin, Jonathan L. [9 ]
机构
[1] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Sect Cardiol, 1 Baylor Plaza, Houston, TX 77030 USA
[2] Kent State Univ, Dept Comp Sci, Kent, OH 44242 USA
[3] Case Western Reserve Univ, Harrington Heart & Vasc Inst, Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
[4] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA
[5] NYU, Dept Cardiovasc Med, Long Isl Sch Med, New York, NY USA
[6] Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA
[7] Mayo Clin, Evidence Based Practice Ctr, Rochester, MN USA
[8] Mayo Clin, Div Hlth Care Policy & Res, Dept Hlth Sci Res, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA
[9] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Mt Sinai Heart, New York, NY 10029 USA
关键词
D O I
10.1016/j.cjca.2021.11.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical databases, particularly those composed of big data, face growing security challenges. Blockchain, the open, decentralized, distributed public ledger technology powering cryptocurrency, records transactions securely without the need for third-party verification. In the health care setting, decentralized blockchain networks offer a secure interoperable gateway for clinical research and practice data. Here, we discuss recent advances and potential future directions for the application of blockchain and its integration with artificial intelligence (AI) in cardiovascular medicine. We first review the basic underlying concepts of this technology and contextualise it within the spectrum of current, well known applications. We then consider specific applications for cardiovascular medicine and research in areas such as high-throughput gene sequencing, wearable technologies, and clinical trials. We then evaluate current challenges to effective implementation and future directions. We also summarise the health care applications that can be realised by combining decentralized block chain computing platforms (for data security) and AI computing (for data analytics). By leveraging high-performance computing and AI capable of securely managing large and rapidly expanding medical databases, blockchain incorporation can provide clinically meaningful predictions, help advance research methodology (eg, via robust AI-blockchain decentralized clinical trials), and provide virtual tools in clinical practice (eg, telehealth, sensory-based technologies, wearable medical devices). Integrating AI and blockchain approaches synergistically amplifies the strengths of both technologies to create novel solutions to serve the objective of providing precision cardiovascular medicine.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 48 条
[1]   Artificial intelligence and multi agent based distributed ledger system for better privacy and security of electronic healthcare records [J].
Alruwaili, Fahad F. .
PEERJ COMPUTER SCIENCE, 2020,
[2]  
[Anonymous], 2017, CTTI Recommendations: Registry Trials
[3]  
[Anonymous], International Clinical Trials Registry Platform
[4]  
[Anonymous], 2020, Embedding Equity into Emergency Operations: Strategies for Local Health Departments during COVID-19 and Beyond
[5]  
Aragam KG, 2020, J AM COLL CARDIOL, V75, P2769, DOI 10.1016/j.jacc.2020.04.027
[6]   Personalized Virtual Cardiac Resynchronization Therapy Simulation Based on a 12-Lead ECG and CMR Predicts Electrical Activation Changes After Cardiac Resynchronization Therapy [J].
Bilchick, Kenneth C. ;
Lluch, Eric ;
Oomen, Pim ;
Gao, Xu ;
Holmes, Jeffrey W. ;
Kramer, Christopher M. ;
Mansi, Tommaso .
CIRCULATION, 2020, 142
[7]  
Blum K, 2009, GENE THER MOL BIOL, V13A, P91
[8]   The Genesy Model for a Blockchain-Based Fair Ecosystem of Genomic Data [J].
Carlini, Federico ;
Carlini, Roberto ;
Dalla Palma, Stefano ;
Pareschi, Remo ;
Zappone, Federico .
FRONTIERS IN BLOCKCHAIN, 2020, 3
[9]   SPIRIT 2013: new guidance for content of clinical trial protocols [J].
Chan, An-Wen ;
Tetzlaff, Jennifer M. ;
Altman, Douglas G. ;
Dickersin, Kay ;
Moher, David .
LANCET, 2013, 381 (9861) :91-92
[10]  
Gaskell A., 2017, Forbes